Pierre Corvol

Active 1970–2019

147
Papers
32,000
Citations
99
h-index
147
i10-index

Citations

Citations per year for Pierre Corvol1971: 5 citations1972: 11 citations1973: 9 citations1974: 6 citations1975: 9 citations1976: 12 citations1977: 7 citations1978: 9 citations1979: 15 citations1980: 7 citations1981: 12 citations1982: 13 citations1983: 27 citations1984: 32 citations1985: 21 citations1986: 29 citations1987: 44 citations1988: 23 citations1989: 38 citations1990: 35 citations1991: 58 citations1992: 59 citations1993: 99 citations1994: 158 citations1995: 232 citations1996: 199 citations1997: 248 citations1998: 265 citations1999: 233 citations2000: 315 citations2001: 258 citations2002: 250 citations2003: 302 citations2004: 257 citations2005: 253 citations2006: 278 citations2007: 210 citations2008: 213 citations2009: 185 citations2010: 234 citations2011: 201 citations2012: 159 citations2013: 169 citations2014: 152 citations2015: 117 citations2016: 97 citations2017: 85 citations2018: 87 citations2019: 350 citations2020: 408 citations2021: 307 citations2022: 177 citations2023: 114 citations2024: 228 citations2025: 47 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,117 citing papers, 28.8% of this breakdownFrance: 647 citing papers, 8.8% of this breakdownUnited Kingdom: 617 citing papers, 8.4% of this breakdownGermany: 429 citing papers, 5.8% of this breakdownChina: 350 citing papers, 4.8% of this breakdownJapan: 323 citing papers, 4.4% of this breakdownItaly: 289 citing papers, 3.9% of this breakdownCanada: 256 citing papers, 3.5% of this breakdownAustralia: 246 citing papers, 3.4% of this breakdownNetherlands: 240 citing papers, 3.3% of this breakdownSwitzerland: 156 citing papers, 2.1% of this breakdownSpain: 156 citing papers, 2.1% of this breakdown
0%28.8%Other 20.7%

Fields

  • Medicine63.1%
  • Biochemistry, Genetics and Molecular Biology26.6%
  • Neuroscience4.1%
  • Immunology and Microbiology1.6%
  • Nursing0.8%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • Other3.1%

Topics

  • Renin-Angiotensin System Studies9.6%
  • Hormonal Regulation and Hypertension7.9%
  • Receptor Mechanisms and Signaling3.5%
  • Apelin-related biomedical research2.7%
  • Cancer, Hypoxia, and Metabolism2.1%
  • Adrenal and Paraganglionic Tumors2%
  • Other72.2%

Coauthors

All papers

Open in search
  1. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

    Authors: , , , , , - Journal of Clinical Investigation 1990 cited by 3,805

  2. Hypoxia, Hypoxia-Inducible Transcription Factor, and Macrophages in Human Atherosclerotic Plaques Are Correlated With Intraplaque Angiogenesis

    Authors: , , , , , , , , , , , - Journal of the American College of Cardiology 2008 cited by 460

  3. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.

    Authors: , , , , , , , , , - 2003 cited by 548

  4. Robo4 Maintains Vessel Integrity and Inhibits Angiogenesis by Interacting with UNC5B

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Developmental Cell 2011 cited by 210

  5. Molecular basis of human hypertension: Role of angiotensinogen

    Authors: , , , , , , , , , , - Cell 1992 cited by 1,862

  6. Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain

    Authors: , , , , , , , , - Journal of Neurochemistry 2001 cited by 370

  7. ATP6AP2 variant impairs CNS development and neuronal survival to cause fulminant neurodegeneration

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Geneviève Nguyen, Matthias Groszer - Journal of Clinical Investigation 2019 cited by 58

  8. Angiopoietin-Like 4 Is a Proangiogenic Factor Produced during Ischemia and in Conventional Renal Cell Carcinoma

    Authors: , , , , , , , , , , - American Journal Of Pathology 2003 cited by 338

  9. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)

    Authors: , , , - Nucleic Acids Research 1992 cited by 1,253

  10. Soluble Form of the (Pro)Renin Receptor Generated by Intracellular Cleavage by Furin Is Secreted in Plasma

    Authors: , , , , , - Hypertension 2009 cited by 280

  11. Angiotensin-Converting Enzyme C-Terminal Catalytic Domain Is the Main Site of Angiotensin I Cleavage In Vivo

    Authors: , , , , , , , , - Hypertension 2007 cited by 135

  12. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels.

    Authors: , , , , , , - 1992 cited by 1,179

  13. The R22X Mutation of the SDHD Gene in Hereditary Paraganglioma Abolishes the Enzymatic Activity of Complex II in the Mitochondrial Respiratory Chain and Activates the Hypoxia Pathway

    Authors: , , , , , , , - The American Journal of Human Genetics 2001 cited by 366

  14. Multiple Promoters in the WNK1 Gene: One Controls Expression of a Kidney-Specific Kinase-Defective Isoform

    Authors: , , , , , , - Molecular and Cellular Biology 2003 cited by 197

  15. Extracellular Matrix–Bound Angiopoietin-Like 4 Inhibits Endothelial Cell Adhesion, Migration, and Sprouting and Alters Actin Cytoskeleton

    Authors: , , , , , , , , , , - Circulation Research 2006 cited by 193

  16. Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness

    Authors: , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 250

  17. Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Labrune, Yu Sui, Helen V. Firth, Diana Wellesley, Martin Bitzan, Ahmed Alfares, Nancy Braverman, Lotte Krogh, John Tolmie, Harald Gaspar, Bérénice Doray, Silvia Majore, Dominique Bonneau, Stéphane Triau, Chantal Loirat, Albert David, Deborah Bartholdi, Amir Peleg, Damien Brackman, Rosário Stone, Ralph J. DeBerardinis, Pierre Corvol, Annie Michaud, Corinne Antignac, Marie-Claire Gübler - Human Mutation 2011 cited by 128

  18. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning.

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1988 cited by 755

  19. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active

    Authors: , , , - Journal of Biological Chemistry 1991 cited by 383

  20. The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice.

    Authors: , , , , , , - Journal of Clinical Investigation 1997 cited by 278

  21. Efficacy and tolerance of spironolactone in essential hypertension

    Authors: , , , , , , , - The American Journal of Cardiology 1987 cited by 271

  22. Aminopeptidase A inhibitors as potential central antihypertensive agents

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 193

  23. Mapping of a First Locus for Autosomal Dominant Myxomatous Mitral-Valve Prolapse to Chromosome 16p11.2-p12.1

    Authors: , , , , , , , , , - The American Journal of Human Genetics 1999 cited by 181

  24. Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient mice

    Authors: , , , , , , , , - Journal of Clinical Investigation 2000 cited by 168